Weight-loss injections: ‘Two years ago I had to use a mobility scooter, this year I am hiking’
High costs are a common worry among users of Ozempic, Mounjaro and other weight-loss drugs, who report varying levels of success
obesity
stories related to people with obesity
‘Obesity medications may not make you thin or happy but they will improve your health’
GLP-1 drugs need to be reframed in the public mind as an essential medical treatment rather than ‘skinny jabs’, say practitioners
The drivers of obesity that also come with climate impacts
Thinking in a Climate Emergency: ultraprocessed foods are a leading cause of rising rates of obesity
Eli Lilly’s weight-loss breakthroughs face brutal investor scrutiny
Perfection was priced in, anything less provoked panic as shares were hit with worst one-day drop in 25 years
Eli Lilly obesity pill disappoints in trial, sending shares down 14%
Weight loss comes in at lower end of expectations and triggers stock boost for rival Novo Nordisk
Liver cancer: ‘The saddest part is that most of the cases are preventable’
On current trends, number of new annual diagnoses will almost double by 2050
Novo Nordisk cuts sales forecasts on lower US demand for obesity drug
First-quarter sales rise 18 per cent but Danish pharma group blames custom preparations at pharmacies for weaker take-up
Pfizer’s Irish staff fear for jobs as drugmaker seeks another €1.5bn in cuts
Pharma giant now looking for $7.7bn in annual savings by 2027 as it grapples with falling post-Covid sales and lack of new blockbusters
Lilly’s weight loss pill is a ‘landmark moment’ in the obesity fight
Prof Donal O’Shea hails breakthrough and says it may play key role in reshaping treatments
Weight loss drug Wegovy to cost around €220 a month as supplies go on market in Ireland
Weight loss drug is not yet approved for reimbursement under Drug Payment Scheme or for medical card patients
Generic drugmaker races to launch versions of blockbuster obesity drugs
Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year
Novo Nordisk to explore how obesity drugs can help patients with addiction
Danish obesity drug giant looking at whether its semaglutide drug can reduce cravings associated with addiction
More than half of adults will be obese or overweight by 2050, study finds
Spiralling rates of people who are obese and overweight a ‘monumental societal failure’
Insurers will not cover obesity drugs that will cost users €2,500-plus a year
Patients looking to access Eli Lilly’s Mounjaro from next week will have to pay privately
Human psychology: ‘Even being told you are old could affect things like blood pressure’
Research Lives: Dr Deirdre Robertson is a senior researcher at the behavioural research unit, ESRI
‘It’s kind of become our daughter’s cheat meal’: The view on new hot school meals programme
The scheme now covers nearly 2,200 schools, and 345,000 children, but some parents and teachers have concerns about nutritional standards
Novo Nordisk shares tumble as weight-loss drug trial data disappoints
Obesity drug CagriSema misses goal of 25% body weight reduction
It’s time for a reality check about certain ‘weight loss’ drugs, and here’s why
Much hype surrounds drugs called GLP-1 agonists but they are intended for diabetes patients and people who are obese, not those who just want to lose a few pounds
Chief obesity clinician Prof Donal O’Shea ‘shocked’ at prevalence of black market ‘skinny jabs’
RTÉ Investigates programme to be aired on Monday examines illegitimate sales of weight loss drugs, despite some being labelled as ‘not for human use’
Lilly’s Zepbound tops Novo Nordisk’s Wegovy for weight loss in head-to-head trial
Companies competing for leadership in fast-growing market where supply continues to be an issue
Prof Donal O’ Shea: ‘The positioning of Ronald McDonald House at the entrance to the new children’s hospital makes me angry’
Prof Donal O’ Shea is the HSE lead on obesity and a regular commentator on the dangers of marketing ‘junk and fast food’ to children
Robert Kennedy jnr: Pharma investors brace for impact
Vaccine makers and companies manufacturing breakthrough obesity drugs saw share prices fall on nomination
Covid factor chills profits at pharma group West
US packaging giant backing huge demand for injectable obesity drugs to fill the gap left by falling demand for Covid vaccines
Pharma packaging group West announces 330 jobs for Dublin
Announcement is first major investment by a US multinational following Trump victory in presidential election
Britain’s anti-obesity jab plan is the stuff of sci-fi
Drastic action is considered essential, but this is part of a wider strategy that represents a looming calamity for Stormont
Goodbye BMI, hello BRI: Is roundness a better measure of health than mass?
BMI is criticised for treating fat and muscle mass the same. Does a newer measure solve the problem?
Lilly turns to Ireland to produce two of the hottest therapy areas in medicine
Company is investing $2.8bn in two Irish plants to produce its in-demand weight loss drugs and a new Alzheimer’s therapy
As a cardiologist, here is what I tell my patients about Ozempic
Using such medications to lose excess fat that risks your health is no more of a moral failing than using a blood pressure medication to lower high blood pressure that increases your risk of stroke
‘I see my belly, and my belly sees me. Yes, my diet has really gone belly up’
Enda Sheppard: I resemble more and more a front-loading camel, stocking up for the long winter ahead. Except it’s nowhere near winter
Plain packaging worked to reduce smoking. Unhealthy food should be next
Removing branding from cigarette boxes has reduced smoking among young people. We must now do the same with unhealthy food and drinks as childhood obesity can trigger disease in later life
Weight loss drug semaglutide could reduce heart attack risk by 20%, study finds
Active ingredient in brands including Wegovy and Ozempic also found to have brought about cardiovascular benefits for participants in research
Hot school meals: A close look at the ingredients list is not pretty. This is industrial food
While aimed at child health and rolled out impressively fast, school food merits better use of public money by the Government
Ozempic changed the lives of obesity patients. And then we had to stop prescribing it
Patients are being denied access to a potentially life-saving obesity treatment
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
The GlossOpens in new window
Read the digital edition of The Gloss magazine now
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices